NEWS
MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology
MangoRx, a developer of men's health products, announced that its Australian patent application for a new preventive care technology has been accepted. This follows a similar acceptance in Japan. The technology targets respiratory and orally transmitted infections using a formulation with GALALCOOL®️, zinc protoporphyrin IX, and tannins. This patent strengthens their global intellectual property portfolio, especially following MangoRx's recent acquisition of Intramont Technologies' patents. The official patent publication is set for June 6, 2024, with an anticipated deed issuance by September 6, 2024, barring any opposition. This move aligns with MangoRx’s mission to offer advanced health solutions worldwide.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment